Gut microbiota-driven IL-17A production by hepatic γδ T cells enhances neutrophil defense against systemic

Na Pan1,2, Xing Su1, Yifei Meng1

  • 1Microbiology and Immunology Laboratory, School of Life Sciences, Inner Mongolia University, Hohhot, China.

Virulence
|February 9, 2026
PubMed

Insights

The gut microbiota protects against Staphylococcus aureus infections by priming liver immune cells. This process enhances neutrophil response, aiding bacterial clearance and improving host defense.

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • Staphylococcus aureus bloodstream infections present a major clinical challenge due to rising antibiotic resistance and high mortality rates.
  • The gut microbiota's role in modulating systemic immunity and protecting against invasive bacterial infections is recognized but not fully understood.
  • Understanding the gut-liver axis in immunity is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate how the gut microbiota influences hepatic immune responses during early Staphylococcus aureus bloodstream infection.
  • To elucidate the mechanisms by which gut commensals enhance host defense against invasive bacterial pathogens.
  • To identify potential therapeutic targets for improving outcomes in S. aureus infections.

Main Methods:

  • Utilized animal models to study hepatic immune responses to Staphylococcus aureus bloodstream infection.
  • Analyzed the impact of gut microbiota composition on immune cell function, specifically hepatic γδ T cells and neutrophils.
  • Investigated the role of specific commensal bacteria, Limosilactobacillus reuteri, and their metabolites in modulating host defense.

Main Results:

  • Gut microbiota confers protection against systemic S. aureus infection.
  • Commensal microbiota primes hepatic γδ T cells to produce IL-17A, promoting neutrophil recruitment to the liver for bacterial clearance.
  • Disruption of gut microbiota impairs this immune axis, reducing host resistance; Limosilactobacillus reuteri enhances defense via indole metabolites.

Conclusions:

  • A novel gut-liver immune axis exists where gut microbiota orchestrates hepatic γδ T cell function to combat invasive bacterial pathogens.
  • This microbiota-dependent immune pathway establishes an early defense barrier against S. aureus.
  • Targeting this gut-liver axis presents a promising therapeutic avenue for enhancing host defense against S. aureus infections.

Related Concept Videos

Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
9.8K
Defenses Against Pathogens and Herbivores02:26

Defenses Against Pathogens and Herbivores

Plants present a rich source of nutrients for many organisms, making it a target for herbivores and infectious agents. Plants, though lacking a proper immune system, have developed an array of constitutive and inducible defenses to fend off these attacks.
29.6K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.9K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.1K